
@article{ WOS:000831705100001,
Author = {Szymczak-Pajor, Izabela and Wenclewska, Sylwia and Sliwinska, Agnieszka},
Title = {Metabolic Action of Metformin},
Journal = {PHARMACEUTICALS},
Year = {2022},
Volume = {15},
Number = {7},
Month = {JUL},
Abstract = {Metformin, a cheap and safe biguanide derivative, due to its ability to
   influence metabolism, is widely used as a first-line drug for type 2
   diabetes (T2DM) treatment. Therefore, the aim of this review was to
   present the updated biochemical and molecular effects exerted by the
   drug. It has been well explored that metformin suppresses hepatic
   glucose production in both AMPK-independent and AMPK-dependent manners.
   Substantial scientific evidence also revealed that its action is related
   to decreased secretion of lipids from intestinal epithelial cells, as
   well as strengthened oxidation of fatty acids in adipose tissue and
   muscles. It was recognized that metformin's supra-therapeutic doses
   suppress mitochondrial respiration in intestinal epithelial cells,
   whereas its therapeutic doses elevate cellular respiration in the liver.
   The drug is also suggested to improve systemic insulin sensitivity as a
   result of alteration in gut microbiota composition, maintenance of
   intestinal barrier integrity, and alleviation of low-grade inflammation.},
Publisher = {MDPI},
Address = {ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND},
Type = {Review},
Language = {English},
Affiliation = {Szymczak-Pajor, I (Corresponding Author), Med Univ Lodz, Dept Nucle Acid Biochem, 251 Pomorska Str, PL-92213 Lodz, Poland.
   Szymczak-Pajor, Izabela; Sliwinska, Agnieszka, Med Univ Lodz, Dept Nucle Acid Biochem, 251 Pomorska Str, PL-92213 Lodz, Poland.
   Wenclewska, Sylwia, Med Univ Lodz, Dept Internal Med Diabetol \& Clin Pharmacol, 251 Pomorska Str, PL-92213 Lodz, Poland.},
DOI = {10.3390/ph15070810},
Article-Number = {810},
EISSN = {1424-8247},
Keywords = {metformin; hepatic gluconeogenesis; glucose metabolism; lipid metabolism},
Keywords-Plus = {ACTIVATED PROTEIN-KINASE; ORGANIC CATION TRANSPORTERS; MITOCHONDRIAL
   GLYCEROL-3-PHOSPHATE DEHYDROGENASE; GLUCAGON-LIKE PEPTIDE-1; BROWN
   ADIPOSE-TISSUE; GLUCOSE-PRODUCTION; HEPATIC GLUCONEOGENESIS; FATTY-ACID;
   SKELETAL-MUSCLE; GUT MICROBIOTA},
Research-Areas = {Pharmacology \& Pharmacy},
Web-of-Science-Categories  = {Chemistry, Medicinal; Pharmacology \& Pharmacy},
Author-Email = {izabela.szymczak@umed.lodz.pl
   sylwia.wenclewska@umed.lodz.pl
   agnieszka.sliwinska@umed.lodz.pl},
Affiliations = {Medical University Lodz; Medical University Lodz},
ResearcherID-Numbers = {Sliwinska, Agnieszka/S-9813-2016
   },
ORCID-Numbers = {Sliwinska, Agnieszka/0000-0002-6864-0704
   Szymczak-Pajor, Izabela/0000-0002-6545-579X},
Funding-Acknowledgement = {Medical University of Lodz {[}503/1-159-01/503-21-001]},
Funding-Text = {This study and paper were supported by a grant from the Medical
   University of Lodz (No. 503/1-159-01/503-21-001).},
Cited-References = {Alshawi A, 2019, J BIOL CHEM, V294, P2839, DOI 10.1074/jbc.RA118.006670.
   Amer Diabet Assoc, 2020, DIABETES CARE, V43, pS98, DOI 10.2337/dc20-S009.
   Bailey CJ, 2008, DIABETOLOGIA, V51, P1552, DOI 10.1007/s00125-008-1053-5.
   BAILEY CJ, 1994, BRIT J PHARMACOL, V112, P671, DOI 10.1111/j.1476-5381.1994.tb13128.x.
   Barberà A, 2003, DIABETOLOGIA, V46, P1394, DOI 10.1007/s00125-003-1206-5.
   Bridges HR, 2014, BIOCHEM J, V462, P475, DOI 10.1042/BJ20140620.
   Calza G, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00141.
   Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491.
   Cao J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00163-w.
   Cao J, 2014, J BIOL CHEM, V289, P20435, DOI 10.1074/jbc.M114.567271.
   CARLING D, 1987, FEBS LETT, V223, P217, DOI 10.1016/0014-5793(87)80292-2.
   CARLSON CA, 1973, J BIOL CHEM, V248, P378.
   CEDERBAU.AI, 1973, ARCH BIOCHEM BIOPHYS, V158, P763, DOI 10.1016/0003-9861(73)90571-7.
   CHAPPELL JB, 1963, J BIOL CHEM, V238, P410.
   Chen EC, 2015, MOL PHARMACOL, V88, P75, DOI 10.1124/mol.114.096776.
   Chen Y, 2009, PHARMACOGENOMICS J, V9, P127, DOI 10.1038/tpj.2008.19.
   Choi MK, 2007, BIOPHARM DRUG DISPOS, V28, P501, DOI 10.1002/bdd.576.
   Churpek JE., 1993, GeneReviews().
   Coll AP, 2020, NATURE, V578, P444, DOI 10.1038/s41586-019-1911-y.
   Cusi K, 1996, J CLIN ENDOCR METAB, V81, P4059, DOI 10.1210/jc.81.11.4059.
   DAVIDOFF F, 1968, J CLIN INVEST, V47, P2331, DOI 10.1172/JCI105918.
   Day EA, 2019, NAT METAB, V1, P1202, DOI 10.1038/s42255-019-0146-4.
   DEFRONZO RA, 1995, NEW ENGL J MED, V333, P541, DOI 10.1056/NEJM199508313330902.
   Di Magno L, 2020, CELL REP, V30, P1735, DOI 10.1016/j.celrep.2020.01.024.
   Duca FA, 2015, NAT MED, V21, P506, DOI 10.1038/nm.3787.
   Dykens JA, 2008, TOXICOL APPL PHARM, V233, P203, DOI 10.1016/j.taap.2008.08.013.
   Eamin EE, 2013, J NUTR, V143, P1872, DOI 10.3945/jn.113.179549.
   El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223.
   EVANS PF, 1983, BIOCHEM PHARMACOL, V32, P3459, DOI 10.1016/0006-2952(83)90377-5.
   Fernie AR, 2004, CURR OPIN PLANT BIOL, V7, P254, DOI 10.1016/j.pbi.2004.03.007.
   Fischer M, 2010, DIABETES OBES METAB, V12, P356, DOI 10.1111/j.1463-1326.2009.01169.x.
   Foretz M, 2019, NAT REV ENDOCRINOL, V15, P569, DOI 10.1038/s41574-019-0242-2.
   Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671.
   Forslund K, 2015, NATURE, V528, P262, DOI 10.1038/nature15766.
   Fullerton MD, 2013, NAT MED, V19, P1649, DOI 10.1038/nm.3372.
   GAN SC, 1992, ARCH INTERN MED, V152, P2333, DOI 10.1001/archinte.152.11.2333.
   Geerling JJ, 2014, DIABETES, V63, P880, DOI 10.2337/db13-0194.
   Gong DW, 1998, DNA CELL BIOL, V17, P301, DOI 10.1089/dna.1998.17.301.
   Gong L, 2012, PHARMACOGENET GENOM, V22, P820, DOI 10.1097/FPC.0b013e3283559b22.
   Gontier E, 2008, EUR J NUCL MED MOL I, V35, P95, DOI 10.1007/s00259-007-0563-6.
   Gormsen LC, 2019, DIABETOLOGIA, V62, P1251, DOI 10.1007/s00125-019-4872-7.
   Grisouard J, 2010, BIOCHEM PHARMACOL, V80, P1736, DOI 10.1016/j.bcp.2010.08.021.
   Grosskopf I, 1997, DIABETES CARE, V20, P1598, DOI 10.2337/diacare.20.10.1598.
   Guo ZJ, 2017, CELL CHEM BIOL, V24, P1259, DOI 10.1016/j.chembiol.2017.08.009.
   Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311.
   HARDING JW, 1975, BIOCHEM J, V146, P223, DOI 10.1042/bj1460223.
   Hattori Y, 2006, HYPERTENSION, V47, P1183, DOI 10.1161/01.HYP.0000221429.94591.72.
   Hawley SA, 2002, DIABETES, V51, P2420, DOI 10.2337/diabetes.51.8.2420.
   He L, 2015, CELL METAB, V21, P159, DOI 10.1016/j.cmet.2015.01.003.
   HOLLUNGER G, 1955, Acta Pharmacol Toxicol (Copenh), V11, P1.
   Hundal RS, 2000, DIABETES, V49, P2063, DOI 10.2337/diabetes.49.12.2063.
   Hunter RW, 2018, NAT MED, V24, P1395, DOI 10.1038/s41591-018-0159-7.
   Inzucchi SE, 1998, NEW ENGL J MED, V338, P867, DOI 10.1056/NEJM199803263381303.
   Iversen AB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10010-z.
   Jakobsen S, 2016, J NUCL MED, V57, P615, DOI 10.2967/jnumed.115.169292.
   JEPPESEN J, 1994, DIABETES CARE, V17, P1093, DOI 10.2337/diacare.17.10.1093.
   Jin HE, 2009, PHARM RES-DORDR, V26, P549, DOI 10.1007/s11095-008-9770-5.
   Jornayvaz FR, 2010, ESSAYS BIOCHEM, V47, P69, DOI {[}10.1042/bse0470069, 10.1042/BSE0470069].
   Karise I, 2019, BIOMED PHARMACOTHER, V111, P1156, DOI 10.1016/j.biopha.2019.01.021.
   Kim EK, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/5813030.
   Kim MH, 2014, J ENDOCRINOL, V220, P117, DOI 10.1530/JOE-13-0381.
   Kimura Naoko, 2005, Drug Metab Pharmacokinet, V20, P379, DOI 10.2133/dmpk.20.379.
   King P, 1999, BRIT J CLIN PHARMACO, V48, P643, DOI 10.1046/j.1365-2125.1999.00092.x.
   Koffert JP, 2017, DIABETES RES CLIN PR, V131, P208, DOI 10.1016/j.diabres.2017.07.015.
   Konopka AR, 2016, CELL REP, V15, P1394, DOI 10.1016/j.celrep.2016.04.024.
   Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967.
   Koza RA, 1996, ARCH BIOCHEM BIOPHYS, V336, P97, DOI 10.1006/abbi.1996.0536.
   Kristensen JM, 2014, AM J PHYSIOL-ENDOC M, V306, pE1099, DOI 10.1152/ajpendo.00417.2013.
   LANOUE KF, 1971, METABOLISM, V20, P119, DOI 10.1016/0026-0495(71)90087-4.
   Larsen S, 2012, DIABETOLOGIA, V55, P443, DOI 10.1007/s00125-011-2340-0.
   Leclerc I, 2001, DIABETES, V50, P1515, DOI 10.2337/diabetes.50.7.1515.
   Lee A, 1998, OBES RES, V6, P47, DOI 10.1002/j.1550-8528.1998.tb00314.x.
   Lee JO, 2012, J BIOL CHEM, V287, P44121, DOI 10.1074/jbc.M112.361386.
   Lewis AJM, 2016, DIABETES, V65, P3544, DOI 10.2337/db16-0804.
   Li WJ, 2019, AGING DIS, V10, P949, DOI 10.14336/AD.2019.0120.
   Li XY, 2019, G3-GENES GENOM GENET, V9, P513, DOI 10.1534/g3.118.200803.
   LIETZ T, 1995, ARCH BIOCHEM BIOPHYS, V321, P501, DOI 10.1006/abbi.1995.1423.
   Lietz T, 1997, ACTA BIOCHIM POL, V44, P323.
   MACDONALD MJ, 1981, J BIOL CHEM, V256, P8287.
   Madiraju AK, 2018, NAT MED, V24, P1384, DOI 10.1038/s41591-018-0125-4.
   Madiraju AK, 2014, NATURE, V510, P542, DOI 10.1038/nature13270.
   Mannucci E, 2004, DIABETES NUTR METAB, V17, P336.
   Martin-Montalvo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3192.
   Masuda S, 2006, J AM SOC NEPHROL, V17, P2127, DOI 10.1681/ASN.2006030205.
   McCreight LJ, 2016, DIABETOLOGIA, V59, P426, DOI 10.1007/s00125-015-3844-9.
   MCGARRY JD, 1978, J BIOL CHEM, V253, P4128.
   Meng SM, 2015, J BIOL CHEM, V290, P3793, DOI 10.1074/jbc.M114.604421.
   Migoya EM, 2010, CLIN PHARMACOL THER, V88, P801, DOI 10.1038/clpt.2010.184.
   Mihaylova MM, 2011, CELL, V145, P607, DOI 10.1016/j.cell.2011.03.043.
   Miller RA, 2013, NATURE, V494, P256, DOI 10.1038/nature11808.
   Müller J, 2005, BIOCHEM PHARMACOL, V70, P1851, DOI 10.1016/j.bcp.2005.09.011.
   Musi N, 2002, DIABETES, V51, P2074, DOI 10.2337/diabetes.51.7.2074.
   Napolitano A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100778.
   Natali A, 2019, DIABETES OBES METAB, V21, P412, DOI 10.1111/dom.13519.
   NURJHAN N, 1992, J CLIN INVEST, V89, P169, DOI 10.1172/JCI115558.
   Nygaard EB, 2012, EXP DIABETES RES, DOI 10.1155/2012/465282.
   Oakhill JS, 2012, TRENDS ENDOCRIN MET, V23, P125, DOI 10.1016/j.tem.2011.12.006.
   Okamura H, 2007, CELL BIOL INT, V31, P119, DOI 10.1016/j.cellbi.2006.09.014.
   Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607.
   Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314.
   Polianskyte-Prause Z, 2019, FASEB J, V33, P2858, DOI 10.1096/fj.201800529RR.
   PUHAKAINEN I, 1992, J CLIN ENDOCR METAB, V75, P789, DOI 10.1210/jc.75.3.789.
   Qi HY, 2018, DIABETOLOGIA, V61, P445, DOI 10.1007/s00125-017-4445-6.
   Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450.
   Radziuk J, 1997, DIABETES, V46, P1406, DOI 10.2337/diabetes.46.9.1406.
   Rajasurya V, 2019, CUREUS J MED SCIENCE, V11, DOI 10.7759/cureus.4739.
   Rebrin K, 1996, J CLIN INVEST, V98, P741, DOI 10.1172/JCI118846.
   Repiscák P, 2014, BIOCHEMISTRY-US, V53, P787, DOI 10.1021/bi401444n.
   Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214.
   Sato T, 2016, METABOLISM, V65, P1646, DOI 10.1016/j.metabol.2016.08.005.
   Sato T, 2008, BIOCHEM PHARMACOL, V76, P894, DOI 10.1016/j.bcp.2008.07.005.
   Savage DB, 2006, J CLIN INVEST, V116, P817, DOI 10.1172/JCI27300.
   Scarpello JHB, 1998, DIABETIC MED, V15, P651, DOI 10.1002/(SICI)1096-9136(199808)15:8<651::AID-DIA628>3.3.CO;2-1.
   Scheen AJ, 2013, DIABETES METAB, V39, P179, DOI 10.1016/j.diabet.2013.02.006.
   Scheen AJ, 1996, CLIN PHARMACOKINET, V30, P359, DOI 10.2165/00003088-199630050-00003.
   Schommers P, 2017, MOL METAB, V6, P737, DOI 10.1016/j.molmet.2017.05.002.
   Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781.
   Shin NR, 2014, GUT, V63, P727, DOI 10.1136/gutjnl-2012-303839.
   Shingaki T, 2015, PHARM RES-DORDR, V32, P2538, DOI 10.1007/s11095-015-1642-1.
   Shirasaka Y, 2022, J PHARM SCI-US, V111, P1531, DOI 10.1016/j.xphs.2022.01.008.
   Shu Y, 2008, CLIN PHARMACOL THER, V83, P273, DOI 10.1038/sj.clpt.6100275.
   Soeters PB, 2021, CLIN NUTR, V40, P2988, DOI 10.1016/j.clnu.2021.02.012.
   Song SM, 2001, AM J PHYSIOL-ENDOC M, V281, pE275, DOI 10.1152/ajpendo.2001.281.2.E275.
   Soty M, 2015, MOL METAB, V4, P106, DOI 10.1016/j.molmet.2014.12.009.
   Takashima M, 2010, DIABETES, V59, P1608, DOI 10.2337/db09-1679.
   Thakur S, 2018, CLIN CANCER RES, V24, P4030, DOI 10.1158/1078-0432.CCR-17-3167.
   Toyama EQ, 2016, SCIENCE, V351, P275, DOI 10.1126/science.aab4138.
   TUCKER GT, 1981, BRIT J CLIN PHARMACO, V12, P235.
   Vasamsetti SB, 2015, DIABETES, V64, P2028, DOI 10.2337/db14-1225.
   Victor VM, 2015, EUR J ENDOCRINOL, V173, P683, DOI 10.1530/EJE-15-0572.
   Virtanen KA, 2003, DIABETES, V52, P283, DOI 10.2337/diabetes.52.2.283.
   Wang C, 2014, CLIN LAB, V60, P887, DOI 10.7754/Clin.Lab.2013.130531.
   Wang DS, 2002, J PHARMACOL EXP THER, V302, P510, DOI 10.1124/jpet.102.034140.
   Wang Y, 2019, CELL REP, V29, P1511, DOI 10.1016/j.celrep.2019.09.070.
   WILCOCK C, 1991, J PHARM PHARMACOL, V43, P442, DOI 10.1111/j.2042-7158.1991.tb03507.x.
   WILCOCK C, 1994, XENOBIOTICA, V24, P49, DOI 10.3109/00498259409043220.
   Winiarska K, 1998, ACTA BIOCHIM POL, V45, P825, DOI 10.18388/abp.1998\_4278.
   Wu H, 2017, NAT MED, V23, P850, DOI 10.1038/nm.4345.
   Wu TZ, 2014, DIABETES RES CLIN PR, V106, pE3, DOI 10.1016/j.diabres.2014.08.004.
   Xie JJ, 2020, CANCER RES, V80, P2150, DOI 10.1158/0008-5472.CAN-19-2852.
   Yaribeygi H, 2019, J CELL PHYSIOL, V234, P8152, DOI 10.1002/jcp.27603.
   Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855.
   Zhang CS, 2016, CELL METAB, V24, P521, DOI 10.1016/j.cmet.2016.09.003.
   Zhang Q, 2020, DIABET METAB SYND OB, V13, P5003, DOI 10.2147/DMSO.S286430.
   Zheng Y, 2019, HEPATOLOGY, V70, P84, DOI 10.1002/hep.30507.
   Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505.
   Zhou MY, 2007, DRUG METAB DISPOS, V35, P1956, DOI 10.1124/dmd.107.015495.},
Number-of-Cited-References = {147},
Times-Cited = {30},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {15},
Journal-ISO = {Pharmaceuticals},
Doc-Delivery-Number = {3G9ZU},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000831705100001},
OA = {Green Published, gold},
DA = {2024-09-07},
}
